Childhood cancer survival varies by tumor stage at diagnosis

A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children’s cancer has spread at diagnosis in a way that can be compared between countries. While poorer survival following late-stage diagnosis is well recognised, the study is the first … Read more

New technique effectively identifies aggressive medulloblastoma

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma-the most common type of malignant brain tumor in children-and potentially sparing young patients from unnecessary treatments and their harmful long-term side effects. The technique, spearheaded by researchers from UBC’s department of pathology and laboratory medicine, BC Cancer and BC Children’s Hospital, can help … Read more

Breakthrough drug improves treatment of medulloblastoma in mice

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard treatments have long-term impacts on their development and quality of life, particularly in small children and infants. Research out of Emory University and QIMR Berghofer Medical Research Institute in Queensland, Australia, has shown that a potential new targeted … Read more